Xylo-oligosaccharide (XOS) is a polymer of sugar xylose, which is produced from xylan fraction in the plant fiber. Xylo-oligosaccharides were in use since ancient time though they were not popular as compared to other carbohydrates such as sugar and edible polymer. Xylo-oligosaccharides are naturally found in fruits, vegetables, bamboo shoots, milk, honey and others. Utility of xylo-oligosaccharides are not only limited for its neutraceuticals properties but it is also widely used in food and beverages industry and as a source of animal feed.
Xylo-oligosaccharide offers major economic advantage as it is produced from agricultural waste. The waste generated from agro industries mainly consists of plant biomass that can be converted into non-digestible sugars. XOS have great potential as a prebiotic, which helps in reduction of LDL cholesterol, maintaining intestinal pH value, and improves immunological systems.
Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2150
Market Dynamics- Drivers
Growing use of xylo-oglisaccharide in various applications such as neutraceuticals & pharmaceuticals and food & beverages is expected to drive growth of the global xylo-oglisaccharide market during the forecast period. In food & beverages industry, XOS is used as an additive in soy milk, soft drinks, jams, honey, tea, cocoa drinks, and dairy products (such as milk and yoghurt) to formulate healthy food. XOS offers prebiotic benefits and has exceptional health benefits including enhancing absorption of calcium, reduces risk of colon cancer, improvement in bowel function, and act as an antioxidant. Thus health benefits offered by xylo-oglisaccharide is expected to drive the global xylo-oligosaccharides market growth over the forecast period.
Furthermore, popularity and increasing consumption of prebiotics is projected to boost demand for xylo-oligosaccharide in the forecast period. According to U.S. Department of Health & Human Services, the consumption of prebiotics and probiotics by adults in the U.S. has increased by four times during 2012 – 2007.
However, heavy investment and expensive equipment are required for production of xylo-oligosaccharides. Moreover, production of xylo-oligosaccharides generates unwanted products such as furfural and hydroxymethyl furfural in the mixture of XOS which can cause skin allergy. Therefore, these factors, in turn, are expected to restrain growth of the global xylo-oligosaccharides market over the forecast period.
Among applications, neutraceuticals & pharmaceuticals segment accounted for the highest market share in the global xylo-oligosaccharides market in 2017. This is owing to various advantages offered by XOS such as water binding capacity, sweetening ability, and fat replacement value. Moreover, xylo-oligosaccharides have a host of health benefits such as it act as an anti-allergic, antioxidant, and anti-inflammatory. Such advantages will attract more pharmaceuticals & neutraceuticals companies to adopt xylo-oligosaccharides as a non-digestible sugar in their products.
Among regions, North America held the highest market share in the global xylo-oligosaccharides market in 2017 and is estimated to remain dominance during the forecast period. This is owing to rising health awareness among consumers. According to U.S. Department of Health & Human Services, 3.9 million adult population consumed prebiotic or probiotic products in 2016.
Furthermore, Asia Pacific is expected to be the fastest growing region in the market over the forecast period. This growth is attributed to increasing number of pharmaceutical industries and rising incidence of diabetes in the region. For instance, according to Indian Brand Equity Foundation (IBEF), pharmaceutical industry is the third-largest industry in India in terms of volume and accounted for around 20% of the global pharmaceutical industries in 2017. Asia is home to most diabetic patients in the world. In 2017, according to International Diabetes Federation, diabetic population of India and China accounted for 8.8% and 10.9% of the total adult’s diabetic population of the respective countries.
Key Players in Global Xylo-oligosaccharides market
Key players operating in the global xylo-oligosaccharides market include Fengyuan Zhongke, Hebi Taixin, Hengfeng Sugar, Huaian Baimai Keyu, Kanwei Biologic, Longlive, Suntory, Suzhou Xiankuo, and Yatai.
Key players in the market are involved in various growth strategies such as product launch, in order to gain competitive edge in the market. For instance, in March 2018, Wonder Drink Company launched Prebiotic Kombucha, an innovated drink that adds prebiotic in its existing product.
Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/2150
Moreover, key players are adopting business strategies such as mergers and acquisition, in order to enhance their market presence. For instance, in April 3, 2018, UAS Laboratories LLC, a probiotic company acquired Nebraska Cultures, a neutraceuticals company. This merger will help UAS Laboratories to cater the market of nutraceuticals and the company will continue the production of spore-based probiotics, Lactobacillus acidophilus DDS-1 and ProDura.
On the basis of product type, the global xylo-oligosaccharides market is segmented into:
On the basis of application, the global xylo-oligosaccharides market is segmented into:
– Neutraceuticals & Pharmaceuticals
– Food & Beverages
Based on the region, the global artificial turf market is segmented into:
– North America
– Asia Pacific
– Latin America
– Middle East
Mr. Raj Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Visit Our Blog: https://globalindustryresearchsite.wordpress.com